找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders; IOIS Guidelines Uwe Pleyer,Jorge L. Alió,Narsing A. Rao Book 2014 The

[复制链接]
查看: 31100|回复: 49
发表于 2025-3-21 19:34:00 | 显示全部楼层 |阅读模式
书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders
副标题IOIS Guidelines
编辑Uwe Pleyer,Jorge L. Alió,Narsing A. Rao
视频video
概述Most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation.All recommendations graded according to the strength of supporting evidence.Includes suggestions f
图书封面Titlebook: Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders; IOIS Guidelines Uwe Pleyer,Jorge L. Alió,Narsing A. Rao Book 2014 The
描述These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject.
出版日期Book 2014
关键词Evidence based medicine; Immune modulatory agents; Inflammatory diseases; Ocular immunology; Surgical ap
版次1
doihttps://doi.org/10.1007/978-3-642-54350-0
isbn_softcover978-3-662-50738-4
isbn_ebook978-3-642-54350-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE
The information of publication is updating

书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders影响因子(影响力)




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders影响因子(影响力)学科排名




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders网络公开度




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders网络公开度学科排名




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders被引频次




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders被引频次学科排名




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders年度引用




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders年度引用学科排名




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders读者反馈




书目名称Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:05:27 | 显示全部楼层
发表于 2025-3-22 00:29:37 | 显示全部楼层
发表于 2025-3-22 08:04:30 | 显示全部楼层
发表于 2025-3-22 11:35:48 | 显示全部楼层
Cystoid Macular Edema,patients is estimated between 20 and 30 % and is a major cause of permanent vision loss [1–3]. About 35 % of uveitis patients with a vision less than 0.1 (6/60) have macular edema, though its prevalence as a cause of poor vision varies with the duration of uveitis. It is reported in 17 % of cases at year 1 and increases to 30 % by year 5 [4].
发表于 2025-3-22 13:19:08 | 显示全部楼层
978-3-662-50738-4The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE
发表于 2025-3-22 20:46:35 | 显示全部楼层
发表于 2025-3-22 21:41:47 | 显示全部楼层
Treatment of Inflammation Secondary to Vitreoretinal Surgery,Vitreoretinal surgery is comprised of a number of techniques, and any of them can cause inflammation for different reasons. This chapter will focus on the treatment of inflammation caused by scleral buckling, pars plana vitrectomy, and combined procedure phacovitrectomy.
发表于 2025-3-23 04:51:50 | 显示全部楼层
发表于 2025-3-23 08:02:42 | 显示全部楼层
Diagnosis and Management of Scleritis,cond-line immunosuppressive agents. Subconjunctival corticosteroid injection may be an option in non-necrotising noninfectious anterior scleritis, particularly in those who fail to respond to initial systemic therapy. Biologic agents, particularly infliximab and rituximab, may prove useful in refrac
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-22 15:05
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表